Medacta Discloses First Surgeries in Japan Using Its Augmented Reality Surgical Platform - Marketscreener.com

1 year ago 43

Delayed Swiss Exchange  -  11:30:42 2023-01-10 americium EST 107.80 CHF   +0.37%

01/10/2023 | 11:30pm EST MT Newswires 2023 All quality about MEDACTA GROUP SA 01:03p Medacta Group Sa : First NextAR surgeries successful Japan with the award-winning NextAR Augmented.. EQ 2022 Global markets live: Amazon, Berkshire Hathaway, Infineon, Home Depo.. 2022 Medacta Settles Patent Disputes Over Knee, Shoulder Implants With Conformis MT 2022 Medacta Group SA announces the last colony successful the Conformis case EQ 2022 Medacta Says First US Hip Surgery Carried Out With Double Mobility Converter MT 2022 Medacta Group Sa : Medacta Expands its Hip Offerings with New Cobalt-Free SensiTiN™ .. EQ 2022 Medacta NextAR Spine wins the 2022 Spine Technology Award from Orthopedics This Week du.. EQ 2022 Medacta's MySpine Anchor Technology Used successful First US Procedure MT 2022 Medacta announces the archetypal MySpine Anchor process completed successful the US EQ 2022 Medacta's MyKnee R Platform Becomes Part Of Revision Surgeries In US MT Analyst Recommendations on MEDACTA GROUP SA 2021 Medacta : Credit Suisse Lifts Price Target connected Medacta Group, Maintains Neutral R.. MT 2021 Medacta : Octavian Lifts Price Target connected Medacta Group, Maintains Buy Recommenda.. MT 2021 Medacta : Octavian Lifts Price Target connected Medacta Group, Maintains Buy Recommenda.. MT		Financials Sales 2022 429 M 461 M 461 M Net income 2022 56,2 M 60,3 M 60,3 M Net Debt 2022 123 M 132 M 132 M P/E ratio 2022 38,6x Yield 2022 0,55% Capitalization 2 174 M 2 336 M 2 336 M EV / Sales 2022 5,36x EV / Sales 2023 4,69x Nbr of Employees 1 421 Free-Float 30,4% Chart MEDACTA GROUP SA Duration : Period : Technical investigation trends MEDACTA GROUP SA Short Term Mid-Term Long Term Trends Bullish Bullish Neutral Income Statement Evolution Consensus Sell Buy Mean consensus OUTPERFORM Number of Analysts 4 Last Close Price 108,83 € Average people price 107,65 € Spread / Average Target -1,08% EPS Revisions Managers and Directors Francesco Siccardi Chief Executive Officer Corrado Farsetta Chief Financial Officer Alberto Siccardi Non-Executive Chairman Victor Waldemar Balli Lead Independent Non-Executive Director Philippe A. Weber Independent Non-Executive Director Sector and Competitors 1st jan. Capi. (M$) MEDACTA GROUP SA 4.27% 2 338 ABBOTT LABORATORIES 2.31% 195 542 MEDTRONIC PLC 4.04% 103 142 BECTON, DICKINSON AND COMPANY 1.98% 71 763 DEXCOM, INC. 2.28% 42 512 HOYA CORPORATION -0.51% 34 207

1. Homepage
2. Technology
3. Medacta Discloses First Surgeries in Japan Using Its Augmented Reality Surgical Platform - Marketscreener.com